Published in Conf Proc IEEE Eng Med Biol Soc on August 01, 2015
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology (2002) 3.29
The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil (2005) 3.17
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes (2007) 2.73
Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med (2007) 2.17
Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia (2015) 2.11
The epidermal growth factor receptor: from development to tumorigenesis. Differentiation (2007) 2.07
Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension (2006) 1.91
Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation (2005) 1.89
Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol (2004) 1.69
The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med (2007) 1.61
Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab (2007) 1.58
Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients. Obesity (Silver Spring) (2011) 1.54
A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol (2006) 1.54
Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology (2003) 1.53
First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol (2004) 1.53
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke (2013) 1.53
Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J (2004) 1.52
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes (2002) 1.51
Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol (2003) 1.51
Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations. Transplantation (2011) 1.48
In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun (2009) 1.45
Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab (2006) 1.45
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol (2012) 1.44
Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract (2005) 1.41
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab (2006) 1.41
T-wave variability for the prediction of fast ventricular arrhythmias – prospective, observer-blind study. Circ J (2014) 1.40
Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology (2005) 1.34
Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. Diabetes Care (2005) 1.34
Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care (2004) 1.32
Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2005) 1.27
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26
Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin Chem (2004) 1.25
Inflammation alters HDL composition and function: implications for HDL-raising therapies. Pharmacol Ther (2012) 1.23
Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis (2005) 1.23
Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab (2003) 1.22
Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care (2002) 1.21
Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care (2005) 1.21
Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes (2003) 1.20
Simvastatin prevents vascular hyporeactivity during inflammation. Circulation (2004) 1.20
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol (2006) 1.18
Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care (2007) 1.16
The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr (2006) 1.16
Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes. Diabetes (2009) 1.15
Non-invasive glucose monitoring: assessment of technologies and devices according to quantitative criteria. Diabetes Res Clin Pract (2006) 1.12
Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab (2002) 1.09
Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure. Arterioscler Thromb Vasc Biol (2007) 1.07
Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus. Diabetes Care (2010) 1.06
Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) (2008) 1.05
The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care (2007) 1.05
Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci (2009) 1.04
Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes (2003) 1.03
Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer (2003) 1.02
Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology (2009) 1.02
Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab (2006) 1.02
Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects. J Am Coll Cardiol (2003) 1.02
Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. Am J Physiol Endocrinol Metab (2003) 1.02
Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. J Clin Endocrinol Metab (2011) 1.01
Report of the 1st meeting of the "Vienna Initiative to Save European Academic Research (VISAER)". Wien Klin Wochenschr (2006) 1.01
Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol (2006) 1.00
Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One (2012) 1.00
Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parameters. PLoS One (2012) 0.99
Glucose metabolism after renal transplantation. Diabetes Care (2013) 0.99
Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clin Sci (Lond) (2008) 0.99
Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2007) 0.99
Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas. J Clin Endocrinol Metab (2002) 0.98
Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care (2009) 0.98
Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab (2004) 0.98
Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol (2002) 0.97
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice. Am J Physiol Endocrinol Metab (2005) 0.97
Assessment of batch to batch variation in polyclonal antithymocyte globulin preparations. Transplantation (2012) 0.96
Comparison of measuring energy metabolism by different (31) P-magnetic resonance spectroscopy techniques in resting, ischemic, and exercising muscle. Magn Reson Med (2011) 0.96
Heme arginate improves reperfusion patterns after ischemia: a randomized, placebo-controlled trial in healthy male subjects. J Cardiovasc Magn Reson (2012) 0.96
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity. Transpl Int (2010) 0.96
Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial. J Cardiovasc Magn Reson (2011) 0.96
Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite. Eur J Endocrinol (2014) 0.95
Hyperglycemia affects flicker-induced vasodilation in the retina of healthy subjects. Vision Res (2003) 0.95
High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation (2002) 0.95
Differential development of glucose intolerance and pancreatic islet adaptation in multiple diet induced obesity models. Nutrients (2012) 0.95
Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome. Mol Med (2010) 0.95
Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci (2003) 0.95
Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis (2007) 0.95
Subdiaphragmatic vagal deafferentation affects body weight gain and glucose metabolism in obese male Zucker (fa/fa) rats. Am J Physiol Regul Integr Comp Physiol (2005) 0.95
Correlation of flicker-induced and flow-mediated vasodilatation in patients with endothelial dysfunction and healthy volunteers. Diabetes Care (2009) 0.94
Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab (2004) 0.94
Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci (Lond) (2013) 0.93
Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery. Diabetes Care (2012) 0.93